Please login to the form below

Not currently logged in
Email:
Password:

Merck Serono CEO joins L’Oreal board

Belén Garijo named independent director at beauty company

Belén Garijo Belén Garijo – the present CEO of Merck Serono – has been appointed to the board of beauty company L'Oreal.

Garijo, who took up her current role at pharma company Merck Serono in September last year, will now also serve as an independent director at L'Oreal for a period of four years.

Garijo joined Merck Serono as chief operating officer in 2011. In addition to her current role as CEO she has served as interim global head of R&D at parent company Merck KGaA since the departure of Annalisa Jenkins earlier this year.

Before joining Merck, Garijo served as senior VP, global operations region Europe at Sanofi. During her time at Sanofi, she also took on the role of global integration leader for the company's acquisition of the biotech Genzyme.

Prior to her career in the industry Garijo worked for six years as a practicing physician.

23rd April 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...